Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.84% |
| 2 | Technology | 15.57% |
| 3 | Consumer Discretionary | 11.88% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Denali Therapeutics
DNLI
$3.89B
| $6.94M | 0.01% |
249,600
-142,600
| -36% | -$4.24M |
|
1302
Paysafe
PSFE
$330M
| $6.93M | 0.01% |
498,924
+163,724
| +49% | +$2.65M |
|
|
SFBS
1303
ServisFirst Bancshares
SFBS
$5.02B
| $6.91M | 0.01% |
100,332
+53,232
| +113% | +$3.98M |
|
1304
Integra LifeSciences
IART
$1.42B
| $6.91M | 0.01% |
123,200
-207,573
| -63% | -$10.6M |
|
1305
First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF
LMBS
$6.4B
| $6.9M | 0.01% |
+145,600
| New | +$6.88M |
|
1306
VanEck Gold Miners ETF
GDX
$27.4B
| $6.9M | 0.01% |
240,800
-117,200
| -33% | -$3.13M |
|
1307
Compañía de Cervecerías Unidas
CCU
$2.19B
| $6.9M | 0.01% |
525,866
-183,799
| -26% | -$2.11M |
|
|
NOA
1308
North American Construction
NOA
$378M
| $6.9M | 0.01% |
516,000
-59,300
| -10% | -$731K |
|
1309
Allient
ALNT
$1.88B
| $6.89M | 0.01% |
198,072
-29,150
| -13% | -$961K |
|
1310
Hamilton Lane
HLNE
$5.84B
| $6.89M | 0.01% |
107,831
+29,100
| +37% | +$1.94M |
|
1311
TriNet
TNET
$3.15B
| $6.88M | 0.01% |
101,500
-161,100
| -61% | -$11.1M |
|
1312
Coursera
COUR
$1.53B
| $6.86M | 0.01% |
580,200
-19,700
| -3% | -$248K |
|
1313
Nexstar Media Group
NXST
$5.78B
| $6.86M | 0.01% |
39,205
-5,900
| -13% | -$1.04M |
|
|
CNR
1314
Core Natural Resources Inc
CNR
$4.74B
| $6.86M | 0.01% |
105,503
-315,500
| -75% | -$21.3M |
|
|
CIVI
1315
DELISTED
Civitas Resources
CIVI
| $6.85M | 0.01% |
118,307
+61,800
| +109% | +$3.98M |
|
1316
Acacia Research
ACTG
$444M
| $6.85M | 0.01% |
1,626,400
-114,400
| -7% | -$448K |
|
1317
iShares Preferred and Income Securities ETF
PFF
$13.3B
| $6.84M | 0.01% |
+224,200
| New | +$6.97M |
|
|
PCSB
1318
DELISTED
PCSB Financial Corporation
PCSB
| $6.81M | 0.01% |
357,882
-5,000
| -1% | -$96.3K |
|
|
AD
1319
Array Digital Infrastructure
AD
$3.12B
| $6.79M | 0.01% |
325,562
-11,900
| -4% | -$284K |
|
|
BVH
1320
DELISTED
Bluegreen Vacations Holding Corporation
BVH
| $6.78M | 0.01% |
271,661
-2,800
| -1% | -$57.7K |
|
1321
Global Industrial
GIC
$1.48B
| $6.77M | 0.01% |
287,874
-20,100
| -7% | -$521K |
|
|
AVEO
1322
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $6.76M | 0.01% |
452,000
+291,400
| +181% | +$4.03M |
|
1323
Pricesmart
PSMT
$5.55B
| $6.69M | 0.01% |
110,065
-7,600
| -6% | -$496K |
|
1324
Hingham Institution for Saving
HIFS
$686M
| $6.68M | 0.01% |
24,208
-400
| -2% | -$105K |
|
1325
National Health Investors
NHI
$3.58B
| $6.67M | 0.01% |
+127,824
| New | +$7.01M |
|
Similar funds
Jim Simons's Q4 2022 Portfolio in Review
As of Q4 2022, Jim Simons held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Jim Simons added most to Apple in Q4 2022, an estimated $839M increase.
- Jim Simons's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Jim Simons fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Jim Simons's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Jim Simons opened 626 new positions and closed 524 in Q4 2022.
- Jim Simons's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.